Sitafloxacin

Sitafloxacin
Clinical data
Routes of; administration	Oral
ATC code	J01MA21 (WHO) ;
Legal status
Legal status	In general: ℞ (Prescription only);
Identifiers
	IUPAC name 7-[(4S)-4-Amino-6-azaspiro[2.4]heptan-6-yl]-8-chloro-6-fluoro-1-[(2S)-2-fluorocyclopropyl]-4-oxoquinoline-3-carboxylic acid;
CAS Number	127254-12-0 ;
PubChem CID	461399;
ChemSpider	405945 ;
UNII	3GJC60U4Q8;
KEGG	D02475 ;
ChEMBL	ChEMBL108821 ;
Chemical and physical data
Formula	C19H18ClF2N3O3
Molar mass	409.81 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES F[C@H]5C[C@H]5N2/C=C(/C(=O)O)C(=O)c1cc(F)c(c(Cl)c12)N4C[C@@H](N)C3(CC3)C4;
	InChI InChI=1S/C19H18ClF2N3O3/c20-14-15-8(17(26)9(18(27)28)5-25(15)12-4-10(12)21)3-11(22)16(14)24-6-13(23)19(7-24)1-2-19/h3,5,10,12-13H,1-2,4,6-7,23H2,(H,27,28)/t10-,12+,13+/m0/s1 ; Key:PNUZDKCDAWUEGK-CYZMBNFOSA-N ;
(what is this?) (verify)

Sitafloxacin (INN; also called DU-6859a) is a fluoroquinolone antibiotic[1] that shows promise in the treatment of Buruli ulcer. The molecule was identified by Daiichi Sankyo Co., which brought ofloxacin and levofloxacin to the market. Sitafloxacin is currently marketed in Japan by Daiichi Sankyo under the tradename Gracevit.

References

Anderson, DL. (Jul 2008). "Sitafloxacin hydrate for bacterial infections". Drugs Today (Barc). 44 (7): 489–501. doi:10.1358/dot.2008.44.7.1219561. PMID 18806900.

External links

(in Japanese) Gracevit グレースビット (PDF) Daiichi Sankyo Co. January 2008.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[1] Anderson, DL. (Jul 2008). "Sitafloxacin hydrate for bacterial infections". Drugs Today (Barc). 44 (7): 489–501. doi:10.1358/dot.2008.44.7.1219561. PMID 18806900.

Sitafloxacin

See also

References

Further reading

External links